Testosterone undecanoate (TU) has potential as androgen therapy for ovariectomized female to male (FtM) transsexual subjects; however, the long-term physiologic effects of TU treatment, the significance of testosterone (T), and the T metabolites dihydrotestosterone (DHT) and estradiol (E) on specific outcome parameters are currently unknown.
Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals / Meriggiola, Maria Cristina; Armillotta, Francesca; Costantino, Antonietta; Altieri, Paola; Saad, Farid; Kalhorn, Thomas; Perrone, Anna Myriam; Ghi, Tullio; Pelusi, Carlotta; Pelusi, Giuseppe. - In: JOURNAL OF SEXUAL MEDICINE. - ISSN 1743-6095. - 5:10(2008), pp. 2442-53-???. [10.1111/j.1743-6109.2008.00909.x]
Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals
GHI, Tullio;
2008-01-01
Abstract
Testosterone undecanoate (TU) has potential as androgen therapy for ovariectomized female to male (FtM) transsexual subjects; however, the long-term physiologic effects of TU treatment, the significance of testosterone (T), and the T metabolites dihydrotestosterone (DHT) and estradiol (E) on specific outcome parameters are currently unknown.| File | Dimensione | Formato | |
|---|---|---|---|
|
testosterone alone vs combined with letrozole in F to M_2008.pdf
solo utenti autorizzati
Descrizione: articolo principale
Tipologia:
Altro materiale allegato
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
168.99 kB
Formato
Adobe PDF
|
168.99 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
